Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 19718-49-1 | MDL No. : | MFCD00090423 |
Formula : | C8H8INO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MRLVFVTVXSKAMX-UHFFFAOYSA-N |
M.W : | 277.06 | Pubchem ID : | 4104649 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 54.84 |
TPSA : | 52.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.08 cm/s |
Log Po/w (iLOGP) : | 2.01 |
Log Po/w (XLOGP3) : | 2.69 |
Log Po/w (WLOGP) : | 1.67 |
Log Po/w (MLOGP) : | 2.21 |
Log Po/w (SILICOS-IT) : | 1.94 |
Consensus Log Po/w : | 2.1 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.49 |
Solubility : | 0.0896 mg/ml ; 0.000323 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.44 |
Solubility : | 0.1 mg/ml ; 0.000362 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.06 |
Solubility : | 0.24 mg/ml ; 0.000865 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.67 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With N,N,N-trimethylbenzenemethanaminium dichloroiodate; calcium carbonate In methanol; dichloromethaneHeating / reflux | A solution of methyl 4-aminobenzoate (5.0 g; 0.033 mol.), benzyltrimethylammonium dichloroiodate (22.1 g; 0.056 mol.) and calcium carbonate (5.0 g; 0.050 mol.) in a mixture of dichloromethane (200 ml) and methanol (100 ml_) were stirred and heated under reflux overnight. The solution was cooled, washed with saturated sodium bisulphate, dried and evaporated to afford the desired product (9.6 g; quant.) which was used directly EPO <DP n="32"/>without further purification. 1 H NMR (400 MHz, DMSOd6) δ ppm 3.75 (s, 3 H) 6.09 (s, 2 H) 6.75 (d, J=8.59 Hz, 1 H) 7.66 (dd, J=8.59, 2.02 Hz, 1 H) 8.11 (d, J=2.02 Hz, 1 H). |
100% | With N,N,N-trimethylbenzenemethanaminium dichloroiodate; calcium carbonate In methanol; dichloromethaneHeating / reflux | A solution of methyl 4-aminobenzoate (5.0 g; 0.033 mol.), benzyltrimethylammonium dichloroiodate (22.1 g; 0.056 mol.) and calcium carbonate (5.0 g; 0.050 mol.) in a mixture of dichloromethane(200 ml) and methanol (100 ml.) were stirred and heated under reflux overnight. The solution was cooled, washed with saturated sodium bisulphate, dried and evaporated to afford the desired product (9.6 g; quant.) which was used directly without further purification. 1 H NMR (400 MHz, DMSOd6) δ ppm 3.75 (s, 3 H) 6.09 (s, 2 H) 6.75 (d, J=8.59 Hz, 1 H)7.66 (dd, J=8.59, 2.02 Hz, 1 H) 8.1 1 (d, J=2.02 Hz, 1 H). |
93% | With pyridine iodine monochloride In methanol for 2 h; Reflux; Inert atmosphere | To a stirred solution of methyl 4-aminobenzoate 18 (1.0 g, 6.62 mmol, 1.0 eq.) in methanol (60 mL) was added pyridinium iodochloride (1.60 g, 6.62 mmol, 1.0 eq.). The reaction mixture was refluxed for 2h under nitrogen atmosphere. After cooling to room temperature, the mixture was concentrated in vacuo. The reaction was diluted with ethyl acetate and washed with brine. The organic layer was dried over MgSO4 and was concentrated in vacuo. The crude was purified by chromatography on silica gel column (cyclohexane/EtOAc, gradient 100:0 to 70:30) and concentrated under reduced pressure to afford the compound 19, as a pale yellow solid (93percent yield); mp 90°C; 1H NMR (CDCl3, 500 MHz) δ 8.33 (d, 4J = 1.9 Hz, 1H), 7.81 (dd, 3J = 8.5 Hz, 4J = 2.0 Hz, 1H), 6.70 (d, 3J = 8.5 Hz, 1H), 4.53 (br s, 2H), 3.85 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 166.0 (CO), 150.9 (Cq), 141.2 (CH), 131.4 (CH), 121.4 (CH), 113.3 (Cq), 82.3 (Cq), 52.0 (CH3); IR (neat, cm-1) ν 3472, 3365, 2997, 2948, 2844, 1684, 1627, 1249, 764. Spectral and analytical data matched with literature.[2] |
90% | With N-iodo-succinimide; [bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) In dichloromethane; toluene at 20℃; for 14 h; | General procedure: To a stirred solution of the substrate (1 mmol) in CH2Cl2 or (CH2Cl)2 (0.1 M) were added Ph3PAuNTf2 (0.025 mmol, 19 mg; complex Ph3PAuNTf2 toluene, 2:1) followed by N-iodosuccinimide (1.1 mmol, 248 mg). The resulting solution was stirred at r.t. or under reflux until complete conversion of the starting material. After removal of the solvent under reduced pressure, the crude material was purified by flash column chromatography using different gradients of hexanes and EtOAc to obtain the pure desired products. |
73% | With Iodine monochloride In acetic acid at 20 - 30℃; for 1 h; | 10,4 g (68,8 [MMOL) 4-AMINOBENZOESaeUREMETHYLESTER] wurden in 100 ml Essigsaeure geloest und mit 11,17 g (68,8 [MMOL)] [LODMONOCHLORID] in 100 ml Essigsaeure versetzt. Dabei stieg die Reaktionstemperatur [AUF 30°C] an. Nach einer Stunde bei Raumtemperatur wurde auf [10percent] ige Natriumhydrogencarbonat-Loesung gegossen, mit Dichlormethan extrahiert, die organische Phase getrocknet und eingeengt. Man erhielt 14 g (73 percent) des gewuenschten Produktes. |
[ 672293-33-3 ]
Methyl 4-amino-5-iodo-2-methylbenzoate
Similarity: 0.97
[ 672293-33-3 ]
Methyl 4-amino-5-iodo-2-methylbenzoate
Similarity: 0.97
[ 672293-33-3 ]
Methyl 4-amino-5-iodo-2-methylbenzoate
Similarity: 0.97